Medical condition
Enzyme Replacement Therapy
Enzyme Replacement Therapy is a medical condition tracked by NovaPharmaNews across 11 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- agalsidase beta (FABRAZYME) Alimentary tract and metabolism (A16)
- imiglucerase (CEREZYME) Alimentary tract and metabolism (A16)
- laronidase (ALDURAZYME) Alimentary tract and metabolism (A16)
- asfotase alfa (STRENSIQ) Alimentary tract and metabolism (A16)
- miglustat (MIGLUSTAT DIPHARMA) Alimentary tract and metabolism (A16)
- sebelipase alfa (KANUMA) Alimentary tract and metabolism (A16)
- eliglustat (CERDELGA) Alimentary tract and metabolism (A16)
- pegunigalsidase alfa (ELFABRIO) Alimentary tract and metabolism (A16)
- avalglucosidase alfa (NEXVIADYME) Alimentary tract and metabolism (A16)
- cipaglucosidase alfa (POMBILITI) Alimentary tract and metabolism (A16)
- olipudase alfa (XENPOZYME) Alimentary tract and metabolism (A16)
Latest Enzyme Replacement Therapy news
FDA Approves RARE-Cure’s Orphan Drug Enzyme Replacement Therapy
The FDA has granted approval for RARE-Cure’s enzyme replacement therapy, a groundbreaking treatment for patients with rare genetic disorders.
Enzyme Replacement Therapy Gaucher: FDA Insights on Efficacy & Safety
This article delves into the FDA's insights on the efficacy and safety of Enzyme Replacement Therapy for Gaucher disease, highlighting key findings and treatment implications.